Ex vivo expanded CD34+ hematopoietic stem cells (exHSCs) therapy (University Of Florida)

N/A

Report date: 2025/06/26 20:00:07

Base Information

Drug NameEx vivo expanded CD34+ hematopoietic stem cells (exHSCs) therapy (University Of Florida)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsOligodendrogliomaEpendymomaGlioblastoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Florida
Inactive CompaniesN/A
Active IndicationsOligodendrogliomaEpendymomaGlioblastoma +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A